Ossification of the posterior longitudinal ligament (OPLL) is a progressive spinal disease characterized by ectopic bone ...

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

The diagnosis of spinal cord lymphoma is often delayed due to the high risks associated with a spinal cord biopsy, the rarity of the disease, and the lack of specificity of its clinicoradiological ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Are you struggling with back pain related to lumbar stenosis? Brad: So stenosis is something that a number of people have. It ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...

McKenzie, a Certified Sleep Science Coach and proclaimed mattress expert, has been writing sleep content in the wellness space for over four years. After earning her certification from the Spencer ...